Beginning Sept. 1, 2024, UnitedHealthcare® Medicare Advantage plans, including Medicare and Medicaid Dual Special Needs Plans (D-SNPs), will require prior authorization for personal long-term continuous glucose monitors (CGMs) for members with any diagnosis other than Type 1 diabetes. When the durable medical equipment (DME) vendor receives a physician order for a CGM, the DME provider must obtain prior authorization for both the device and the supplies. The prior authorization will be effective for a consecutive 12-month period.
This aligns with the Centers for Medicare & Medicaid Services Local Coverage Determination (LCD) L33822. It allows members who require insulin or have problematic hypoglycemia to appropriately receive a CGM in accordance with Medicare guidelines.
The new requirement doesn’t apply to the following:
In addition, this requirement doesn’t apply to members with Type 1 diabetes because these members meet the clinical criteria for CGMs. Providers don’t need to request prior authorization to fill CGM and supply orders for these patients. If a DME provider submits a prior authorization for a CGM for a member with Type 1 diabetes, they’ll receive a message that prior authorization isn’t necessary.
This new requirement applies to the following Healthcare Common Procedure Codes (HCPCs):
You can request prior authorization through the UnitedHealthcare Provider Portal:
To learn more, please see our Changes to continuous glucose monitor prior authorization requirement frequently asked questions.
If you have questions, please reach out to your network contact.
PCA-1-24-00399-Clinical-NN_06182024